Kmc Speciality Hospitals (india) Limited · BSE:KMCSHIL

Kmc Speciality Hospitals (india) — Q4 FY2024 Earnings Presentation

35 slides from Kmc Speciality Hospitals (india)'s earnings presentation, Jun 6, 2024

  1. Slide 1: Regulation 30 intimation letter to BSE

    06th June, 2024 To BSE Limited Corporate Relationship Department P J Towers Dalal Street Fort Mumbai – 400 001. Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 – Investor Presentation Pursuant to Regulation 30 of SEBI (Li

  2. Slide 2: Investor Presentation Q4 FY'2024

    Making great healthcare affordable KMC SPECIALITY HOSPITALS (INDIA) LTD INVESTOR PRESENTATION Q4 FY’2024

  3. Slide 3: Contents

    Contents ABOUT US 3 HOSPITAL OVERVIEW 5 SUSTAINABLE GROWTH STRATEGY 6 MAJOR EVENTS 7 LEADERSHIP TEAM 9 BOARD OF DIRECTORS 11 FY’2024 PERFORMANCE SUMMARY 12 HISTORICAL FINANCIAL PERFORMANCE 24 2

  4. Slide 4: About Us

    PLANS AA pd kauvery hospital ABOUT US

  5. Slide 5: About us

    About us • KMC Speciality Hospitals (India) Limited operates a 250- bedded Multi-Specialty Hospital at Trichy, a major city in the State of Tamil Nadu • The Hospital focusses on providing Multi-Specialty services focused on: • Mother & Child Care Services; • Neurosciences; • Gastro Sciences; • Ortho

  6. Slide 6: Hospital Overview: Key Specialities and Advanced Infrastructure

    Hospital Overview : Key Specialities and Advanced Infrastructure In-Patient flow in & around Tiruchirapalli 2 Healthcare Facilities Operational Beds 1 Existing Facility 250 Beds 3% Cuddalore 1 New Facility (Maa Kauvery)* 200 Beds 5% Perambalur Ariyalur Centre of Excellence 4% Orthopaedics 3% 50% 3%

  7. Slide 7: Sustainable Growth Strategy

    Sustainable Growth Strategy Cutting Edge Technology Stay up-to date on technological advancement for better patient experience and clinical results. Doctors Engagement Model Identifying, attracting and retaining right Clinical talent resulting in better clinical outcomes Quality / Digital Enablement

  8. Slide 8: Major Events

    Major Events Sri Kauvery Medical Care Consistent Financial (India) Ltd acquired KMC Started : performance with 22% Speciality Hospitals India Ltd Neuro Science Department CAGR and reaching a in Oct’2008 with 250 beds milestone of INR 158 Cr in Revenues and EBITDA of 28.0% 2015 2023 2008 2024 2022 20

  9. Slide 9: Sri Kauvery Medical Care (India) Limited (The Group / The Parent)

    Sri Kauvery Medical Care (India) Limited (“The Group / The Parent”)  The Group was founded 25 years ago and currently operates 12 Multi-Speciality Hospitals having over 2,500 beds in capacity across Chennai, Trichy, Bengaluru, Salem, Hosur and Tirunelveli;  7 of the Hospitals are directly run in t

  10. Slide 10: Leadership Team

    Leadership Team Dr. S. Chandrakumar Dr. S. Manivannan Dr. D. Senguttuvan Founder & Executive Chairman Founder & Managing Director SBU Head – Co-Founder, Executive Director & Key Managerial Person • A qualified and experienced  Qualified Anesthesiologist with 20+ years of anesthesiologist and critic

  11. Slide 11: Our vision, mission and values

    Our vision, mission and values 10

  12. Slide 12: Board of Directors

    Board of Directors Mr. Sunil Satyapal Gulati (Independent Director) is a B. Tech degree Dr S Chandrakumar (Executive Chairman) is a passionate holder from the IIT, Delhi and a Gold Medalist from the IIM leader, with over 20 years of reputed clinical experience Ahmedabad. He is an Independent Directo

  13. Slide 13: FY'2024 Performance Summary

    FY’2024 PERFORMANCE SUMMARY 12

  14. Slide 14: FY'2024 Performance Summary

    FY’2024 Performance Summary INR 50.9 Cr INR 30.4 Cr INR 158.9 Cr Margin: 28.2% Total Income Margin: 16.8% EBITDA and Margins % Margins % PAT and FY’23 FY’23 FY’23 180.7 Cr 14% 44.4 Cr 15% 26.7 Cr 14% Margin: 28.0% Margin:16.8% 70,638 INR 25,196 5.0 Occupied Bed Days Blended ARPOB ALOS (days) FY’23 F

  15. Slide 15: Q4 FY'2024 Performance Summary

    Q4 FY’2024 Performance Summary INR 12.6 Cr INR 7.1 Cr INR 45.7 Cr Margin: 27.5% Total Income Margin: 15.5% EBITDA and Margins % Margins % PAT and Q4 FY’23 Q4 FY’23 Q4 FY’23 41.9 Cr 9% 12.1 Cr 4% 7.3 Cr -2% Margin: 28.9% Margin:17.3% 18,154 INR 24,915 5.0 Occupied Bed Days Blended ARPOB ALOS (days) Q

  16. Slide 16: Key operating metrics: Revenue & Profitability

    Key operating metrics : Revenue & Profitability Total Income (INR Cr) EBITDA (INR Cr & margin %) +14% +15% +9% +4% 28.0% 28.2% 28.9% 27.5% Profit before tax (INR Cr & margin %) Profit after tax (INR Cr & margin %) +13% +14% -3% -2% 22.7% 22.4% 23.2% 20.6% 16.8% 16.8% 17.3% 15.5% 14

  17. Slide 17: Key operating metrics: Volumes, Occupancies & ALOS

    Key operating metrics : Volumes, Occupancies & ALOS Average census and occupied beds per day (1) ALOS (days) (2) 92% 94% 97% 97% OPD volumes (3) IPD volumes (4) +14% +7% +7% +4% 15 1.Occupancy is computed based on actual census beds of 205 (out of total 250 beds) 2. ALOS is the average length of sta

  18. Slide 18: Key operating metrics: ARPP, ARPOB & Revenue mix

    Key operating metrics : ARPP, ARPOB & Revenue mix ARPP IP (INR) (1) ARPP OP (INR) (2) +8% +4% +7% +8% Blended ARPOB (INR) (3) Revenue mix by payor category +12% +11% Cash TPA / Corporates Govt. Scheme 16 1. ARPP IP is calculated by In-patient Revenue divided by In-patient Nos 2. ARPP OP is calculate

  19. Slide 19: Diverse Revenue Mix: Significant contribution from specialities

    Diverse Revenue Mix Significant contribution from specialities Mother & child care Services* Neuro Science Gastro Science Critical Care General Medicine Plastic Surgery Orthopaedics Renal Science Haematology Others 17 *Mother & Child care Services include Neonataology, Obstetrics and Gynae and Pedia

  20. Slide 20: Performance Highlights and Commentary

    Performance Highlights and Commentary • Total Income has increased by INR 21.9 Cr. (14%) compared to the previous year; • This was achieved on the back of strong-performance across of all our specialties with increasing trend seen in volumes and revenue mix; • Consistent Strong performance of 24% on

  21. Slide 21: Annexure: Profit & Loss Statement

    Annexure: Profit & Loss Statement Year ended Quarter ended Y-o-Y Growth Y-o-Y Growth INR Cr FY'24 FY'23 Q4 FY'24 Q4 FY'23 % % Income Revenue from operations 177.2 155.8 13.8% 44.9 41.1 9.3% Other income 3.6 3.1 13.8% 0.8 0.9 -9.8% Total income 180.7 158.9 13.8% 45.7 41.9 8.9% Cost of Goods Sold 24.4

  22. Slide 22: Annexure: Balance Sheet

    Annexure: Balance Sheet Equities & Liabilities (INR Cr) FY'24 FY'23 Assets (INR Cr) FY'24 FY'23 Total Equity 143.58 113.50 Non-Current Assets 230.20 129.80 Share Capital 16.31 16.31 Property, Plant and Equipment 195.55 78.36 Other Equity 127.27 97.19 Right-of-Use-Assets 9.65 5.13 Non-Current Liabili

  23. Slide 23: Annexure: Cash Flow Statement

    Annexure: Cash Flow Statement Particluars (INR Cr) FY'24 FY'23 Net Profit After Tax 30.38 26.69 Adjustments for: Non -Cash Items / Other Investment or Financial Items 18.57 16.56 Operating profit before working capital changes 48.95 43.24 Changes in Working Capital (0.42) (1.70) Cash generated from

  24. Slide 24: Annexure: Financial Ratios

    Annexure: Financial Ratios Financial Ratios FY'24 FY'23 Networth (INR Cr) 144 114 (1) Return on Capital Employed (%) 29% 32% Return on Equity (%) 21% 24% (2) Debt Equity Ratio 0.50 0.39 (3) Net Debt / EBITDA (Times) 0.98 0.13 (4) Current Ratio (Times) 0.9 2.9 DSCR (Times) 4.0 9.2 Interest Coverage R

  25. Slide 25: Annexure: Operational Parameters

    Annexure: Operational Parameters Annualised Quarter Key Metrics FY'23 FY'24 Y-o-Y Growth % Q4 FY'23 Q4 FY'24 Y-o-Y Growth % Census Beds 205 205 0% 205 205 0% Occupied Beds 188 193 3% 199 199 0% Average Occupied Bed Days 68,635 70,638 3% 17,945 18,154 1% Avg Occupancy Rate % 92% 94% 97% 97% Blended A

  26. Slide 26: Historical Financial Performance

    HISTORICAL FINANCIAL PERFORMANCE 24

  27. Slide 27: Key operating metrics: Revenue & Profitability

    Key operating metrics : Revenue & Profitability Total Income (INR Cr) EBITDA (INR Cr & margin %) 23.1% 24.1% 28.4% 28.0% Profit before tax (INR Cr & margin %) Profit after tax (INR Cr & margin %) 17.1% 17.3% 23.2% 22.7% 12.0% 12.2% 17.2% 16.8% 25

  28. Slide 28: Key operating metrics: Volumes, Occupancies & ALOS

    Key operating metrics : Volumes, Occupancies & ALOS Average census and occupied beds per day (1) ALOS (days) (2) 76% 63% 79% 92% OPD volumes (3) IPD volumes (4) 26 1.Occupancy is computed based on actual census beds of 205 (out of total 250 beds) 2. ALOS is the average length of stay of patients in

  29. Slide 29: Key operating metrics: ARPP & ARPOB

    Key operating metrics : ARPP & ARPOB ARPP IP (INR) (1) ARPP OP (INR) (2) Blended ARPOB (INR) (3) 27 1. ARPP IP is calculated by In-patient Revenue divided by In-patient Nos 2. ARPP OP is calculated by Out-patient Revenue divided by Out-patient Nos 3. Blended ARPOB is calculated by adding In- patient

  30. Slide 30: Key operating metrics: ROCE & ROE

    Key operating metrics : ROCE & ROE ROCE (1) ROE (2) 37% 31% 32% 29% FY'20 FY'21 FY'22 FY'23 Note: ROCE is calculated by excluding the Loan availed for New facility “Maa Kauvery”, which commenced its operations from January 2024. 28 1. ROCE is calculated as EBIT (Earnings before Interest and Tax) div

  31. Slide 31: Annexures - Historical Profit and Loss Statement

    Annexures - Historical Profit and Loss Statement INR Cr FY'23 FY'22 FY'21 FY'20 Income Revenue from operations 155.8 136.1 102.6 96.2 Other income 3.1 2.1 1.9 1.4 Total income 158.9 138.2 104.6 97.6 Cost of materials consumed 2.9 2.7 2.7 1.5 Purchase of traded goods 20.4 17.9 13.5 13.0 Changes in in

  32. Slide 32: Annexures - Historical Balance Sheet

    Annexures - Historical Balance Sheet Equities & Liabilities (INR Cr) FY'23 FY'22 FY'21 FY'20 Assets (INR Cr) FY'23 FY'22 FY'21 FY'20 Total Equity 113.50 86.80 63.33 50.66 Non-Current Assets 129.80 86.29 78.86 52.29 Share Capital 16.31 16.31 16.31 16.31 Property, Plant and Equipment 78.36 72.53 71.16

  33. Slide 33: Annexures - Historical Cash Flow Statement

    Annexures - Historical Cash Flow Statement Particluars (INR Cr) FY'23 FY'22 FY'21 FY'20 Net Profit Before Tax 26.7 23.7 12.8 16.7 Adjustments for: Non -Cash Items / Other Investment or Financial Items 16.6 14.8 12.1 5.0 Operating profit before working capital changes 43.2 38.5 24.9 21.7 Changes in W

  34. Slide 34: Annexure: Historical Operational Parameters

    Annexure: Historical Operational Parameters Key Metrics FY'23 FY'22 FY'21 FY'20 Census Beds 205 205 197 197 Occupied Beds 188 163 124 150 Average Occupied Bed Days 68,650 59,313 45,260 54,750 Avg Occupancy Rate % 92% 79% 63% 76% Blended ARPOB (INR) 22,438 22,887 22,249 17,578 ALOS (Days) 5.2 5.2 5.0

  35. Slide 35: Thank You

    kauvery hospital THANK YOU

KMC Speciality Hospitals (India) — Q4 FY2024 Earnings Presentation on 6ix